A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor

Experimental Cell Research

Volumn 313, Issue 3, 2007, Pages 527-537

  Mills, Philippe ^a   Lafrenière, Jean François ^a   Benabdallah, Basma Fattouma ^a   El Fahime, El Mostafa ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Fibrinolytic; Insulin like growth factor 1 (IGF 1); Mechano growth factor (MGF); Metalloproteinases; Migration; Muscle; Muscle precursor cell (MPC); Myoblast; u PA

Indexed keywords

CYTOKINE; GELATINASE; GROWTH FACTOR; MECHANO GROWTH FACTOR; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 33846589323     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.10.032     Document Type: Article

References (49)

1. Skuk D., Roy B., Goulet M., Chapdelaine P., Bouchard J.P., Roy R., Dugre F.J., Lachance J.G., Deschenes L., Helene S., Sylvain M., and Tremblay J.P. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 9 (2004) 475-482
2. Skuk D., Goulet M., Roy B., Chapdelaine P., Bouchard J.P., Roy R., Dugre F.J., Sylvain M., Lachance J.G., Deschenes L., Senay H., and Tremblay J.P. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. 65 (2006) 371-386
3. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin. Biol. Ther. 41 (2004) 871-885
4. Lafreniere J.F., Mills P., Bouchentouf M., and Tremblay J.P. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp. Cell Res. 312 (2006) 1127-1141
5. Lafreniere J.F., Mills P., Tremblay J.P., and Fahime E.E. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 77 (2004) 1741-1747
6. Allen D.L., Teitelbaum D.H., and Kurachi K. Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am. J. Physiol.: Cell Physiol. 284 (2003) C805-C815
7. Florini J.R., Ewton D.Z., and Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17 (1996) 481-517
8. Rabinovsky E.D., Gelir E., Gelir S., Lui H., Kattash M., DeMayo F.J., Shenaq S.M., and Schwartz R.J. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 17 (2003) 53-55
9. Adams G.R., and McCue S.A. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J. Appl. Physiol. 84 (1998) 1716-1722
10. Allen R.E., and Boxhorn L.K. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J. Cell. Physiol. 138 (1989) 311-315
11. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., and Schwartz R.J. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270 (1995) 12109-12116
12. Doumit M.E., Cook D.R., and Merkel R.A. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J. Cell. Physiol. 157 (1993) 326-332
13. Engert J.C., Berglund E.B., and Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 135 (1996) 431-440
14. Lawlor M.A., Feng X., Everding D.R., Sieger K., Stewart C.E., and Rotwein P. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol. Cell. Biol. 20 (2000) 3256-3265
15. Lawlor M.A., and Rotwein P. Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol. Cell. Biol. 20 (2000) 8983-8995
16. Shavlakadze T., Winn N., Rosenthal N., and Grounds M.D. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 15 (2005) 4-18
17. Winn N., Paul A., Musaro A., and Rosenthal N. Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. Cold Spring Harbor Symp. Quant. Biol. 67 (2002) 507-518
18. Chew S.L., Lavender P., Clark A.J., and Ross R.J. An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 136 (1995) 1939-1944
19. Daughaday W.H., and Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10 (1989) 68-91
20. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., and Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400 (1999) 581-585
21. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., and Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15603-15607
22. Yang S., Alnaqeeb M., Simpson H., and Goldspink G. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J. Muscle Res. Cell Motil. 17 (1996) 487-495
23. Hill M., and Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J. Physiol. 549 (2003) 409-418
24. Rouille Y., Duguay S.J., Lund K., Furuta M., Gong Q., Lipkind G., Oliva Jr. A.A., Chan S.J., and Steiner D.F. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuroendocrinol. 16 (1995) 322-361
25. Siegfried J.M., Kasprzyk P.G., Treston A.M., Mulshine J.L., Quinn K.A., and Cuttitta F. A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 8107-8111
26. Kuo Y.H., and Chen T.T. Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp. Cell Res. 280 (2002) 75-89
27. Kuo Y.H., and Chen T.T. Specific cell surface binding sites shared by human Pro-IGF-I Eb-peptides and rainbow trout Pro-IGF-I Ea-4-peptide. Gen. Comp. Endocrinol. 132 (2003) 231-240
28. Tian X.C., Chen M.J., Pantschenko A.G., Yang T.J., and Chen T.T. Recombinant E-peptides of pro-IGF-I have mitogenic activity. Endocrinology 140 (1999) 3387-3390
29. Yang S.Y., and Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 522 (2002) 156-160
30. Schultz E., Jaryszak D.L., and Valliere C.R. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8 (1985) 217-222
31. El Fahime E., Mills P., Lafreniere J.F., Torrente Y., and Tremblay J.P. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation. Exp. Cell Res. 280 (2002) 169-178
32. El Fahime E., Torrente Y., Caron N.J., Bresolin M.D., and Tremblay J.P. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp. Cell Res. 258 (2000) 279-287
33. Wojtowicz-Praga S.M., Dickson R.B., and Hawkins M.J. Matrix metalloproteinase inhibitors. Invest. New Drugs 15 (1997) 61-75
34. Wang Y., Jones C.J., Dang J., Liang X., Olsen J.E., and Doe W.F. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells. FEBS Lett. 353 (1994) 138-142
35. Vassalli J.D., and Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 214 (1987) 187-191
36. Suzuki J., Yamazaki Y., Li G., Kaziro Y., and Koide H. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts. Mol. Cell. Biol. 20 (2000) 4658-4665
37. Johnson S.E., and Allen R.E. The effects of bFGF, IGF-I, and TGF-beta on RMo skeletal muscle cell proliferation and differentiation. Exp. Cell Res. 187 (1990) 250-254
38. Charge S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84 (2004) 209-238
39. Chazaud B., Bonavaud S., Plonquet A., Pouchelet M., Gherardi R.K., and Barlovatz-Meimon G. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Exp. Cell Res. 258 (2000) 237-244
40. Andreasen P.A., Kjoller L., Christensen L., and Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72 (1997) 1-22
41. Blasi F., Behrendt N., Cubellis M.V., Ellis V., Lund L.R., Masucci M.T., Moller L.B., Olson D.P., Pedersen N., and Ploug M. The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differ. Dev. 32 (1990) 247-253
42. Mignatti P., and Rifkin D.B. Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv. Cancer Res. 78 (2000) 103-157
43. Cubellis M.V., Wun T.C., and Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 9 (1990) 1079-1085
44. Lewis M.P., Tippett H.L., Sinanan A.C., Morgan M.J., and Hunt N.P. Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures. J. Muscle Res. Cell Motil. 21 (2000) 223-233
45. Caron N.J., Asselin I., Morel G., and Tremblay J.P. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant 8 (1999) 465-476
46. Holnthoner W., Kerenyi M., Groger M., Kratochvill F., and Petzelbauer P. Regulation of matrilysin expression in endothelium by fibroblast growth factor-2. Biochem. Biophys. Res. Commun. 342 (2006) 725-733
47. Wernert N., Gilles F., Fafeur V., Bouali F., Raes M.B., Pyke C., Dupressoir T., Seitz G., Vandenbunder B., and Stehelin D. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res. 54 (1994) 5683-5688
48. Cortes E., te Fong L.F., Hameed M., Harridge S., Maclean A., Yang S.Y., Reid W.M., and Goldspink G. Insulin-like growth factor-1 gene splice variants as markers of muscle damage in levator ani muscle after the first vaginal delivery. Am. J. Obstet. Gynecol. 193 (2005) 64-70
49. Barton E.R. Viral expression of Insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J. Appl. Physiol. (2006) 1778-1784